NCT00458042View on ClinicalTrials.gov

Transitioning To IV Remodulin From Ventavis in Patients With PAH: Safety, Efficacy and Treatment Satisfaction

PHASE4TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2007

Study Completion Date

November 30, 2007

Conditions
Hypertension, Pulmonary
Interventions
DRUG

treprostinil sodium

Trial Locations (2)

92037

UCSD Medical Center Thornton Hospital, La Jolla

92103

UCSD Medical Center Hillcrest Campus, San Diego

Sponsors
All Listed Sponsors
lead

United Therapeutics

INDUSTRY